Substance
LULIZUMAB PEGOL
Global reference: every product and company linked to this substance.
- cas: 1421830-13-8
- ncit: C175727
- unii: LCT264LTYE
BMS-931699 · lulizumab pegol [INN] · LULIZUMAB PEGOL [USAN] · Lulizumab pegol [WHO-DD]
Revenue by product (0)
No revenue reported for this substance in loaded filings.
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.